Mood Stabilisers - PowerPoint PPT Presentation

About This Presentation
Title:

Mood Stabilisers

Description:

Mood Stabilisers Psychopharmacology – PowerPoint PPT presentation

Number of Views:47
Avg rating:3.0/5.0
Slides: 51
Provided by: bar01psy
Category:

less

Transcript and Presenter's Notes

Title: Mood Stabilisers


1
Mood Stabilisers
  • Psychopharmacology

2
Mood Stabilisers
  • The treatment of bipolar disorder may be divided
    into three overlapping phases
  • Acute manic episode
  • Depressive episode
  • Prophylactic treatment
  • Only 1/3 of bipolar patients experience adequate
    relief with a monotherapy.

3
How they work?
  • They have no clear effect on dopamine?? So why
    are they effective in mania?
  • They have no clear effect serotonin?? So why are
    they effective in depressive episodes?

4
Pregnancy categories
5
Lithium
  • First original mood stabiliser
  • Underutilised
  • Appears most effective in treating acute mania
  • First psychiatric drug that required blood level
    monitoring

6
Lithium
  • Manic episodes of bipolar disorder
  • Maintenance treatment for bipolar disorder
  • Bipolar depression
  • Major depressive disorder
  • Vascular headache
  • Neutropenia

7
Mechanisms
  • Generally unknown
  • Complex in action
  • Alters sodium transport across cell membranes
  • Alter metabolism of neurotransmitters
    catecholamines, serotonin, GABA and glutamate
  • May alter intracellular signalling through
    actions on second messenger systems

8
Second messenger systems
  • Method of cellular signalling
  • Cyclic adenosine monophosphate (cAMP)
  • intracellular signal transduction
  • A different process of neurotransmission

9
Lithium
  • Effective within 1-3 weeks
  • Goal of treatment is a remission in symptoms
  • Many patients only have a partial response

10
Concept of Augmentation
  • the combination of two or more drugs to achieve
    better treatment results
  • Failure of monotherapy
  • Better tolerability

11
Pre-testing
  • Kidney function( should be repeated 1-2)
  • Thyroid function
  • ECG for patients over 50
  • Metabolic monitoring
  • Fasting plasma glucose level
  • Cholesterol and triglycerides
  • BMI

12
Side Effects
  • The reason to why lithium causes side effects is
    complex
  • Excessive actions at the same or similar sites
    that mediate actions
  • Renal side effects acts on transportation of ions

13
Side Effects
  • Polyuria
  • Polydipsia
  • Diarrhoea
  • Nausea
  • Weight gain
  • Goiter
  • Acne, rash, alopecia
  • leukocytosis

14
Life Threatening Side Effects
  • Lithium toxicity
  • Renal impairment
  • Nephrogenic diabetes insipidus
  • Arrhythmias
  • Cardiovascular changes\sick sinus rhythm
  • Sick Sinus syndrome
  • Bradycardia
  • hypotension
  • T wave flattening and inversion

15
Toxicity
  • Toxic Levels are very close to therapeutic levels
  • Symptoms
  • Diarrhoea
  • Vomiting
  • Course tremor
  • Delerium
  • Coma
  • Seizures
  • Monitoring for dehydration

16
Dosing and Using
  • 1800mg/day in divided doses (acute)
  • 900-1200mg/day in divided doses( maintenance)
  • Dosage forms
  • 450mg (slow release)
  • 250mg tablets
  • start low and adjust dosage upward as indicated
    by plasma levels

17
Dosing
  • Slow release less gastric irritation, lower peak
    plasma levels and peak dose side effects
  • Use the lowest dose of lithium associated with
    adequate therapeutic response
  • Go low in the elderly
  • Rapid discontinuation increase relapse

18
Monitoring
  • Therapeutic Levels

19
Drug interaction
  • Increase plasma levels
  • NSAIDS
  • Diuretics
  • Angiotensin-converting enzymes
  • Anticonvulsants (carbemazepine and phenytoin)
  • Metronidazole
  • Calcium channel blockers
  • Increase side effects
  • SSRIs
  • Haloperidol

20
Special Populations
  • Elderly
  • Pregnancy
  • Breast feeding

21
Anticonvulsant medications
  • Sodium Valproate
  • Carbemazepine
  • Lamotrogine

22
Sodium Valproate
  • A first line treatment for bipolar disorder
    especially mixed state or rapid cycling bipolar.
  • Prescribed for
  • Mania
  • Maintenance treatment of Bipolar Disorder
  • Seizures
  • Migraine prophylaxis

23
How does it work?
  • Blocks voltage- sensitive sodium channels
  • Increases brain concentrations of
    gamma-aminobutyric acid (GABA)
  • Relatively unknown why it does this

24
Sodium Valproate
  • Effects occur within a few days
  • Optimised at several weeks to one month
  • The goal is to see a remission in symptoms
  • Augmentation

25
Pre-testing
  • Platelet counts
  • Liver function testing
  • Coagulation tests
  • Metabolic monitoring

26
Sides Effects
  • Due to Excessive actions at voltage sensitive
    sodium channels
  • Include
  • - Sedation - dyspepsia
  • - Tremor - weight gain
  • - ataxia - alopecia
  • - tremor - polycystic ovarian syndrome
  • - headache - hyperandrogenisam
  • - Abdominal pain - hyperinsulinemia
  • - nausea/vomiting - Lipid dysregulation
  • - reduced appetite - decreased bone density
  • - constipation

27
Life threatening/Dangerous Side Effects
  • Hepatotoxicity
  • Liver failure
  • Pancreatitis
  • Overdose
  • Restlessness
  • Hallucinations
  • Sedation
  • Heart block
  • Coma

28
Dosage and Use
  • Range
  • Mania 1200-1500mg/day
  • Migraine 500-1000mg/day
  • Epilepsy 10-60mg/day
  • 100mg, 200mg and 500mg tablets
  • Dosages are increased rapidly in the case of
    mania.
  • May need divided dose due to half life
  • Terminal mean half life of 9-16 hours
  • Metabolised by the liver

29
Drug interactions
  • Lamotrogine should be reduced by 50
  • Plasma levels lowered by drugs such as
  • Carbemazepine
  • Phenytoin
  • Plasma levels are increased by drugs such as
  • Aspirin
  • Chlorpromazine
  • Fluoxetine
  • NSAIDS

30
Warnings
  • Hepatotoxicity
  • Malaise
  • Weakness
  • Lethargy
  • Facial edema
  • Anorexia
  • Vomiting
  • Jaundice skin and eyes
  • Pancreatitis
  • Abdominal pain
  • Nausea
  • vomiting

31
Special Populations
  • Elderly
  • Pregnancy
  • Breast feeding
  • Post partum issues

32
Carbamazepine
  • More commonly used to treat seizures
  • First anticonvulsant to be widely used in the
    treatment of Bipolar disorders
  • Potentially an advantage in treatment resistant
    bipolar and or psychotic disorders

33
How it works
  • Blocks voltage sensitive sodium channels
  • Interacts with the open channel conformation of
    sodium channels
  • Inhibits release of glutamate

34
Carbamazepine
  • Goal of treatment is remission of symptoms
  • Effect usually occur within a few weeks
  • Can be used a augment other medications

35
Pre testing
  • Blood count
  • Liver function
  • Kidney function
  • Thyroid function

36
Side effects
  • Sedation
  • Dizziness
  • Confusion
  • Unsteadiness
  • Headache
  • Nausea and vomiting
  • Diarrhoea
  • Blurred vision
  • Benign leukopenia
  • Rash
  • Weight gain

37
Dangerous side effects
  • Rare aplatic anemia
  • Agranulocytosis
  • Ususal bleeding
  • Infections
  • Fever
  • Sore throat
  • Steven Johnson syndrome (RASH)
  • Cardiac issues
  • SIADH

38
Dosage and Use
  • 400-1200 mg/day
  • Comes in slow release
  • Should always be taken with food

39
Pharmacokinetics
  • Metabolised in the liver by CYP450
  • Half life of 26-65 hours initially then drops
    with repeated doses

40
Drug interactions
  • Other antiepileptic medications
  • Fluvoxamine, fluoxtetine
  • Decrease efficacy of benzodiazepines, clozapine,
    haloperidol, lamotrogine, epilum and warfarin
  • Can decrease effectiveness of the contraceptive
    pill
  • Lithium

41
Special Populations
  • Pregnancy Category D
  • Breast Feeding

42
Lamotrigine
  • Seems to be more effective in treating depressive
    episodes of bipolar
  • Used less than other anticonvulsants for Bipolar
    Disorder

43
How it works?
  • Voltage- gated sodium channel agonist
  • Inhibits the release of glutamate

44
Side effects
  • Benign rash (10)
  • Sedation
  • Blurred vision
  • Dizziness
  • Ataxia
  • Headache
  • Tremor
  • Insomnia
  • Poor coordination
  • Fatigue
  • Nausea and vomiting
  • Can cause flu like symptoms in some people

45
Stevens Johnsons Syndrome
  • Rare serious rash
  • Acute fever
  • Bullae on the skin
  • Ulcers on the mucous membranes on lip, eyes,
    mouth and nasal passages
  • Management
  • Stop medication
  • Monitor and investigate organ involvement
  • May require admission

46
Dosage and Use
  • Monotherapy 100- 200 mg/day
  • Halved if used with other medication
  • Monitor for rash

47
Pharmacokinetics
  • Elimination half life 33 hours
  • Higher if used concurrently with other
    anticonvulsant medication
  • Metabolised through the liver

48
Drug interactions
  • Depressive effects may be increased by other CNS
    depressants

49
Special populations
  • People with renal impairment
  • Hepatic Impairment
  • Elderly
  • Children and Adolescents
  • Pregnancy
  • Breast feeding

50
Atypical Antipsychotic Medication
  • Increasing use of antipsychotic medication
  • Olanzapine, Risperidone, Quetiapine, Ziprasidone
    and Aripripazole
Write a Comment
User Comments (0)
About PowerShow.com